{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:36:43Z","timestamp":1791920203096,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31173050"],"award-info":[{"award-number":["31173050"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Program of the National Natural Science Foundation of China","award":["81230081"],"award-info":[{"award-number":["81230081"]}]},{"DOI":"10.13039\/501100013286","name":"Research Fund for the Doctoral Program of Higher Education of China","doi-asserted-by":"crossref","award":["20122307110007"],"award-info":[{"award-number":["20122307110007"]}],"id":[{"id":"10.13039\/501100013286","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ejps.2015.05.009","type":"journal-article","created":{"date-parts":[[2015,5,11]],"date-time":"2015-05-11T19:46:02Z","timestamp":1431373562000},"page":"149-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["The enhancement of cardiac toxicity by concomitant administration of Berberine and macrolides"],"prefix":"10.1016","volume":"76","author":[{"given":"Duo","family":"Zhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan-Feng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Liang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengfeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2015.05.009_b0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4330\/wjc.v2.i4.71","article-title":"Cardiovascular and metabolic effects of Berberine","volume":"2","author":"Affuso","year":"2010","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.ejps.2015.05.009_b0010","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2133\/dmpk.DMPK-12-RG-134","article-title":"Mechanism-based inhibition profiles of erythromycin and clarithromycin with cytochrome P450 3A4 genetic variants","volume":"28","author":"Akiyoshi","year":"2013","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2015.05.009_b0015","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1098\/rsta.2007.0003","article-title":"Modelling transdermal delivery of high molecular weight drugs from microneedle systems","volume":"365","author":"Al-Qallaf","year":"2007","journal-title":"Philos. Trans. Series A Math. Phys. Eng. Sci."},{"key":"10.1016\/j.ejps.2015.05.009_b0020","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1529\/biophysj.104.047290","article-title":"HERG channel (dys)function revealed by dynamic action potential clamp technique","volume":"88","author":"Berecki","year":"2005","journal-title":"Biophysical J."},{"key":"10.1016\/j.ejps.2015.05.009_b0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cbi.2012.01.006","article-title":"Modulations of cytochrome P450 expression in diabetic mice by berberine","volume":"196","author":"Chatuphonprasert","year":"2012","journal-title":"Chemico-biological Interact."},{"key":"10.1016\/j.ejps.2015.05.009_b0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.vascn.2007.03.009","article-title":"Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies","volume":"56","author":"Ducroq","year":"2007","journal-title":"J. Pharmacol. Toxicol. Meth."},{"key":"10.1016\/j.ejps.2015.05.009_b0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1570-0232(02)00754-7","article-title":"Determination of testosterone metabolites in human hepatocytes. I. Development of an on-line sample preparation liquid chromatography technique and mass spectroscopic detection of 6beta-hydroxytestosterone","volume":"784","author":"Friedrich","year":"2003","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ejps.2015.05.009_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.39.1.1","article-title":"Cytochrome P-450 3A4: regulation and role in drug metabolism","volume":"39","author":"Guengerich","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejps.2015.05.009_b0045","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3109\/00498254.2011.597456","article-title":"CYP2D plays a major role in berberine metabolism in liver of mice and humans","volume":"41","author":"Guo","year":"2011","journal-title":"Xenobiotica; the fate of foreign compounds in biological systems"},{"key":"10.1016\/j.ejps.2015.05.009_b0050","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00228-011-1108-2","article-title":"Repeated administration of berberine inhibits cytochromes P450 in humans","volume":"68","author":"Guo","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.05.009_b0055","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0008-6363(00)00265-0","article-title":"Antiarrhythmic drug carvedilol inhibits HERG potassium channels","volume":"49","author":"Karle","year":"2001","journal-title":"Cardiovascular Res."},{"key":"10.1016\/j.ejps.2015.05.009_b0060","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/clpt.2014.41","article-title":"Itraconazole and clarithromycin as ketoconazole alternatives for clinical CYP3A inhibition studies","volume":"95","author":"Ke","year":"2014","journal-title":"Clin. Pharmacol. Therap."},{"key":"10.1016\/j.ejps.2015.05.009_b0065","first-page":"125","article-title":"Inhibitory effects of berberine on IK1, IK, and HERG channels of cardiac myocytes","volume":"22","author":"Li","year":"2001","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejps.2015.05.009_b0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/bdrb.21107","article-title":"Effects of macrolide antibiotics on rat embryonic heart function in vitro","volume":"101","author":"Nilsson","year":"2014","journal-title":"Birth Defects Res. Part B Develop. Reprod. Toxicol."},{"key":"10.1016\/j.ejps.2015.05.009_b0075","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/jac\/dki477","article-title":"In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis","volume":"57","author":"Petersen","year":"2006","journal-title":"J. Antimicrobial Chemotherapy"},{"key":"10.1016\/j.ejps.2015.05.009_b0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1056-8719(97)00013-0","article-title":"Improved high-performance liquid chromatographic procedure for the separation and quantification of hydroxytestosterone metabolites","volume":"37","author":"Purdon","year":"1997","journal-title":"J. Pharmacol. Toxicol. Meth."},{"key":"10.1016\/j.ejps.2015.05.009_b0085","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"New England J. Med."},{"key":"10.1016\/j.ejps.2015.05.009_b0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.fjc.0000191564.52242.00","article-title":"Block of HERG channels by berberine: mechanisms of voltage- and state-dependence probed with site-directed mutant channels","volume":"47","author":"Rodriguez-Menchaca","year":"2006","journal-title":"J. Cardiovascular Pharmacol."},{"key":"10.1016\/j.ejps.2015.05.009_b0095","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature04710","article-title":"HERG potassium channels and cardiac arrhythmia","volume":"440","author":"Sanguinetti","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2015.05.009_b0100","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.yjmcc.2004.09.010","article-title":"Novel C-terminus frameshift mutation, 1122fs\/147, of HERG in LQT2: additional amino acids generated by frameshift cause accelerated inactivation","volume":"37","author":"Sasano","year":"2004","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejps.2015.05.009_b0105","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1055\/s-0030-1270920","article-title":"HERG channel inhibitors in extracts of Coptidis rhizoma","volume":"77","author":"Schramm","year":"2011","journal-title":"Planta Med."},{"key":"10.1016\/j.ejps.2015.05.009_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1027309703313","article-title":"Characterization of the inhibitory effects of erythromycin and clarithromycin on the HERG potassium channel","volume":"254","author":"Stanat","year":"2003","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejps.2015.05.009_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fitote.2013.10.004","article-title":"Inhibitory effects of celastrol on rat liver cytochrome P450 1A2, 2C11, 2D6, 2E1 and 3A2 activity","volume":"92","author":"Sun","year":"2014","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejps.2015.05.009_b0120","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMoa1300799","article-title":"Use of azithromycin and death from cardiovascular causes","volume":"368","author":"Svanstrom","year":"2013","journal-title":"New England J. Med."},{"key":"10.1016\/j.ejps.2015.05.009_b0125","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/1389200013338658","article-title":"Heterotropic cooperativity of cytochrome P450 3A4 and potential drug\u2013drug interactions","volume":"2","author":"Tang","year":"2001","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.ejps.2015.05.009_b0130","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/sj.bjp.0706900","article-title":"No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic-AV block","volume":"149","author":"Thomsen","year":"2006","journal-title":"British J. Pharmacol."},{"key":"10.1016\/j.ejps.2015.05.009_b0135","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1124\/jpet.113.209643","article-title":"Mechanism of hERG channel block by the psychoactive indole alkaloid ibogaine","volume":"348","author":"Thurner","year":"2014","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.ejps.2015.05.009_b0140","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1124\/jpet.302.1.320","article-title":"Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics","volume":"302","author":"Volberg","year":"2002","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.ejps.2015.05.009_b0145","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/ptr.3472","article-title":"Effects of Salvia miltiorrhiza extract on the liver CYP3A activity in humans and rats","volume":"25","author":"Wang","year":"2011","journal-title":"Phytotherapy Res.: PTR"},{"key":"10.1016\/j.ejps.2015.05.009_b0150","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2174\/15680266113139990036","article-title":"Recent developments in computational prediction of HERG blockage","volume":"13","author":"Wang","year":"2013","journal-title":"Curr. Topics Med. Chem."},{"key":"10.1016\/j.ejps.2015.05.009_b0155","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1089\/jmf.2005.8.454","article-title":"Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus","volume":"8","author":"Yu","year":"2005","journal-title":"J. Med. Food"},{"key":"10.1016\/j.ejps.2015.05.009_b0160","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1016\/j.bmcl.2014.06.026","article-title":"Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors","volume":"24","author":"Yun","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2015.05.009_b0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bcp.2012.09.002","article-title":"Arsenic trioxide-induced hERG K(+) channel deficiency can be rescued by matrine and oxymatrine through up-regulating transcription factor Sp1 expression","volume":"85","author":"Zhang","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2015.05.009_b0170","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/jps.23835","article-title":"Microneedle assisted micro-particle delivery from gene guns: experiments using skin-mimicking agarose gel","volume":"103","author":"Zhang","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2015.05.009_b0175","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1159\/000363034","article-title":"Berberine induces hERG channel deficiency through trafficking inhibition","volume":"34","author":"Zhang","year":"2014","journal-title":"Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2015.05.009_b0180","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/sj.bjp.0704859","article-title":"Bertosamil blocks HERG potassium channels in their open and inactivated states","volume":"137","author":"Zitron","year":"2002","journal-title":"British J. Pharmacol."},{"key":"10.1016\/j.ejps.2015.05.009_b0185","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00210-004-0952-3","article-title":"Inhibition of cardiac HERG potassium channels by the atypical antidepressant trazodone","volume":"370","author":"Zitron","year":"2004","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.ejps.2015.05.009_b0190","doi-asserted-by":"crossref","first-page":"10322","DOI":"10.3390\/molecules170910322","article-title":"Antibacterial and synergy of berberines with antibacterial agents against clinical multi-drug resistant isolates of methicillin-resistant Staphylococcus aureus (MRSA)","volume":"17","author":"Zuo","year":"2012","journal-title":"Molecules"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098715002055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098715002055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T06:14:48Z","timestamp":1589523288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098715002055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":38,"alternative-id":["S0928098715002055"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2015.05.009","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The enhancement of cardiac toxicity by concomitant administration of Berberine and macrolides","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2015.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}